Aim: To study possibilities of using depression scales in elderly patients, evaluate the parameters of their reliability and validity and develop practical recommendations on the use of these scales in clinical practice.
Material And Methods: The study included 234 patients, aged over 50 years, with anxious depression. The following scales/questionnaires BDI, GDS-15, CES-D-10, CES-D-20, ZDS and HADS-D were used at baseline and 12 weeks after treatment. Data analysis included the calculation of convergent, discriminative and diagnostic validity of depression scales/questionnaires in elderly.
Results: All scales are effective for the diagnosis of depression in elderly people. The possibility of using these scales in patients with mild cognitive impairment is shown. An increase of the correlation between the scores on depression and anxiety scales up to the loss of discriminative validity of «double» scales/questionnaires by the alternative set of symptoms for the diagnosis of depression and anxiety was confirmed.
Conclusion: Based on the RESULTS: the authors have developed common and specific for each scale recommendations on the optimal use of depression scales/questionnaires in elderly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17116/jnevro201611610151-59 | DOI Listing |
Indian J Psychiatry
September 2024
Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Background: There is a lack of comprehensive data sources on various rating instruments that have been developed, translated, and adapted in Indian context.
Aim: Accordinly, this review aimed to compile the available scales/questionnaires/instruments developed, adapted, and translated for use in India.
Methods: For this, the search engines like PUBMED, Google Scholar, MedKnow, and Science Direct were searched for scales that have been developed, translated, and adapted in Indian context or an Indian language.
Dent J (Basel)
October 2023
Maxillo-Facial Surgery and Dental Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Orofacial pain is a complex experience made up of different features and involving various aspects of life. It has demonstrated a connection, especially when chronic, with conditions such as anxiety, depression, and sleep disorders, through paths that still have not been completely clarified. A deep understanding of orofacial pain and its impact on an individual's life is critical for planning accurate diagnostic and therapeutic approaches.
View Article and Find Full Text PDFPsychiatry Res
October 2022
Department of Psychiatry, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong.
Introduction: With the start of the COVID-19 pandemic, the various social distancing policies imposed have mandated psychiatrists to consider the option of using telepsychiatry as an alternative to face-to-face interview in Hong Kong. Limitations over sample size, methodology and information technology were found in previous studies and the reliability of symptoms assessment remained a concern.
Aim: To evaluate the reliability of assessment of psychiatric symptoms by telepsychiatry comparing with face-to-face psychiatric interview.
J Psychiatr Res
July 2022
Mood Disorders Psychopharmacology Unit, Poul Hansen Family Centre for Depression, University Health Network, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Canadian Rapid Treatment Center of Excellence, Mississauga, ON, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:
While ketamine has been used clinically over the past decades, it has only been recently shown to be a promising therapy for treatment-resistant depression (TRD). However, ketamine and related dissociative agents may also be misused recreationally, creating significant concerns for abuse liability when prescribed for depression. Although the abuse potential of ketamine is widely recognized, there is limited evidence on the differential abuse liability of ketamine enantiomers, (S)-ketamine and (R)-ketamine.
View Article and Find Full Text PDFBJPsych Open
March 2022
Institute of Psychiatric Phenomics and Genomics, University Hospital, LMU Munich, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!